GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Endoscopy/Endoscopic Mucosal and Submucosal Cutting in benign esophageal stricture: Gut | July 2026
22

Endoscopic Mucosal and Submucosal Cutting in benign esophageal stricture: Gut | July 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated July 1, 2026

Introduction:

Long benign esophageal strictures remain one of the most difficult benign conditions to manage. Although endoscopic dilation and incision techniques provide temporary relief, recurrence is common, often requiring repeated interventions. This study introduces a novel endoscopic approach designed to achieve more durable stricture release.

Why was this technique needed?

Conventional balloon dilation and radial incision frequently result in restenosis, especially in long, complex strictures. There is a need for a technique that provides more complete scar release while minimizing repeated procedures.

What did the study show?

  • The technique combines methylene blue-guided visualization of scar tissue with longitudinal mucosal and submucosal cutting down to the muscularis propria, followed by triamcinolone injection.
  • Eleven patients with long benign esophageal strictures underwent the procedure, with eight receiving it as primary treatment.
  • Short-term clinical success was achieved in nearly all patients.
  • Only one patient required repeat treatment during follow-up.
  • The technique appeared feasible and safe, with encouraging outcomes over a mean follow-up of approximately 11 months.

Clinical Impact:

This novel endoscopic approach offers a promising alternative for patients with long or refractory benign esophageal strictures, particularly when conventional dilation or incision techniques have failed. Larger prospective studies are needed to confirm long-term efficacy and safety.

Take-Home Message:

Endoscopic mucosal and submucosal cutting represents an innovative third-space endoscopic technique that may provide more durable relief for long benign esophageal strictures, potentially reducing recurrence and the need for repeated endoscopic interventions.

Related Q&A

23

Economic Impact of POEM and ESD: GIE | June 2026

Introduction: Peroral endoscopic myotomy (POEM) and endoscopic submucosal dissection (ESD) have revolutionized the management of esophageal motility disorders and early gastrointestinal neoplasia. Despite their proven clinical benefits, widespread...

24

Remimazolam Improves Sedation Safety During ERCP : GIE | Jun 2026

Introduction: Deep sedation is essential for successful endoscopic retrograde cholangiopancreatography (ERCP), a technically complex procedure frequently performed in elderly patients and those with significant comorbidities. Propofol remains the...

25

Sustainability Cuts Endoscopy Carbon Footprint and Costs : GIE | Jun 2026

Introduction: Endoscopy services generate substantial amounts of healthcare waste due to high procedural volumes, extensive use of disposable accessories, and stringent infection-control requirements. As healthcare systems increasingly focus...

26

Modern Endoscopic Management of Flat Colonic Neoplasia : Endoscopy | June 2026

Introduction: Non-pedunculated colonic neoplasia (NPCN), including flat and sessile colorectal lesions, is being detected with increasing frequency due to widespread colorectal cancer screening and advances in high-definition endoscopy....

27

EUS-GJ Preferred for Malignant Gastric Outlet Obstruction : GIE | Feb 2026

Introduction: Malignant gastric outlet obstruction (GOO) is a debilitating complication of advanced gastrointestinal and pancreatobiliary cancers, leading to nausea, vomiting, poor oral intake, malnutrition, and impaired quality of...

28

Structured Closure Improves Safety of Duodenal ESD and EFTR : GIE | April 2026

Introduction: Endoscopic submucosal dissection (ESD) and endoscopic full-thickness resection (EFTR) have expanded the therapeutic options for duodenal epithelial and sub epithelial lesions, allowing organ-preserving treatment of lesions that...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer